Back to overview

Barentsz Trial – Bi-parametric MRI versus multi-parametric MRI

Jelle Barentsz (NL) is questioned by Jochen Walz (FR) and Arnaud Villers (FR) about his study on The role of (fast) bi-parametric MRI versus multi-parametric MRI and TRUS-biopsy for detecting clinically significant prostate cancer in biopsy naïve men with elevated PSA .